Leibovich Model
Cross-source consensus on Leibovich Model from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Highlighted claims
- PREDICT-Kidney calculates 10-year recurrence risk using the Leibovich model. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- The model is not appropriate for non-clear cell kidney cancer subtypes, hereditary kidney cancer syndromes or metastatic disease. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- The Leibovich model estimates prognosis after kidney cancer surgery from tumour characteristics. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- For PREDICT-Kidney, the model was adapted to include competing risk from death due to causes other than recurrence. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study